US 7273613
Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
granted A61KA61K2039/57A61K39/00
Quick answer
US patent 7273613 (Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders) held by The Board of Regents of the University of Oklahoma expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2039/57, A61K39/00, A61K39/12, A61K39/245